Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The RNA-directed RNA polymerase (NS5B) of the Hepatitis C virus (HCV) is a viral enzyme essential for the replication of the HCV genome. It catalyzes the synthesis of new viral RNA strands using an existing RNA template, a process central to the virus's life cycle and infectivity. As an essential component in HCV replication, NS5B is a prime target for antiviral drug development. Inhibitors include nucleoside analogs, non-nucleoside inhibitors, and natural compounds like quercetagetin.
Inhibition of viral RNA replication through various mechanisms, including chain termination, allosteric inhibition, and template binding interference.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA-directed RNA Polymerase (Hepatitis C Virus) (NS5B).